Linustedastat

Star0

DB21729ExperimentalSmall molecule

Linustedastat is a small molecule drug. Linustedastat has a monoisotopic molecular weight of 453.22 Da.

Mechanism: Pharmacologically active on 17-beta-hydroxysteroid dehydrogenase type 1
Curator reviewed
Formula / weight: C₂₆H₂₉F₂N₃O₂ · 453.534 g/mol (avg)

Resolves to

Compound

UNIIPP3PLL7GZYCAS2254299-48-2

Structure

InChIKeyRMMVCLGAUPAFAI-MLXDORPZSA-NSMILES[H][C@@]12[C@H](CCC(=O)NC3=CC=C(F)C=N3)C\C(=N/O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C(F)=CC=C3

Targets

P14061HSD17B1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Linustedastat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account